168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar]

Verify with CMS →

estradiol

RxCUI: 545276

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.
0.5%
Plan Coverage
27
Plans Covering
T3.5
Avg Tier
25%
Prior Auth Required

What the CMS Formulary Data Shows for 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar]

Per the CMS 2026 Part D formulary file, 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] (RxNorm concept RXCUI 545276, generic name estradiol) appears on 4 distinct formulary files spanning 27 Medicare Part D plan offerings - 0.5% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 2 to Tier 4, with a cross-plan average of Tier 3.5.

Real-world access to 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] depends on utilization management as much as tier placement: 25% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 404 Part D beneficiaries filled 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] in 2023, with total plan-and-beneficiary spending of $611,837 and an average per-beneficiary annual cost of $1,514.45. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] today.

Coverage Details

Formularies covering
4
Plans covering
27
Coverage rate
0.5%
Tier range
Tier 2 – Tier 4
Average tier
Tier 4, Non-Preferred

Restrictions

Prior authorization required
25% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
404
Total spending
$611,837
Avg per beneficiary
$1,514.45

Tier Distribution Across Plans

1 plans
Tier 2, Generic
26 plans
Tier 4, Non-Preferred

Medicare Advantage Plans (MA-PD) Covering 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar]

27 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
CalOptima Health OneCare Complete (HMO D-SNP) ORANGE COUNTY HEALTH AUTHORITY T2 No $0 CA
Network Health Select (PPO) NETWORK HEALTH INSURANCE CORPORATION T4 No $0 WI
Network Health Go (PPO) NETWORK HEALTH INSURANCE CORPORATION T4 No $0 WI
Network Health Anywhere (PPO) NETWORK HEALTH INSURANCE CORPORATION T4 No $0 WI
Network Health Choice (PPO) NETWORK HEALTH INSURANCE CORPORATION T4 No $0 WI
Network Health Zero (PPO) NETWORK HEALTH INSURANCE CORPORATION T4 No $0 WI
PacificSource Medicare Essentials Rx 27 (HMO) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $0 OR
PacificSource Medicare MyCare Choice Rx 29 (HMO-POS) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $0 MT
PacificSource Medicare Essentials Choice Rx 36 (HMO-POS) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $0 OR
PacificSource Medicare MyCare Rx 40 (HMO) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $0 OR
PacificSource Dual Care (HMO D-SNP) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $0 OR
PacificSource Dual Care Alliance (HMO D-SNP) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $0 OR
PacificSource Medicare MyCare Choice Rx 34 (HMO-POS) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $19.00 ID
Network Health Cares (PPO D-SNP) NETWORK HEALTH INSURANCE CORPORATION T4 No $21.10 WI
PacificSource Medicare Essentials Choice Rx 14 (HMO-POS) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $29.10 OR
Network Health PlusRx (PPO) NETWORK HEALTH INSURANCE CORPORATION T4 No $38.60 WI
Keystone 65 Select Rx (HMO) KEYSTONE HEALTH PLAN EAST, INC. T4 Yes $47.00 PA
PacificSource Medicare MyCare Choice Rx 24 (HMO-POS) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $52.00 ID
Keystone 65 Preferred Rx (HMO) KEYSTONE HEALTH PLAN EAST, INC. T4 Yes $59.70 PA
Keystone 65 Select Rx (HMO) KEYSTONE HEALTH PLAN EAST, INC. T4 Yes $63.50 PA
PacificSource Medicare Essentials Rx 41 (HMO) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $69.30 OR
Keystone 65 Preferred Rx (HMO) KEYSTONE HEALTH PLAN EAST, INC. T4 Yes $79.70 PA
PacificSource Medicare Explorer Rx 4 (PPO) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $88.70 OR
Network Health PremierRx (PPO) NETWORK HEALTH INSURANCE CORPORATION T4 No $92.80 WI
Personal Choice 65 Rx (PPO) QCC INSURANCE COMPANY T4 Yes $102.20 PA
PacificSource Medicare Essentials Rx 6 (HMO) PACIFICSOURCE COMMUNITY HEALTH PLANS T4 No $105.90 OR
Personal Choice 65 Rx (PPO) QCC INSURANCE COMPANY T4 Yes $112.70 PA

Frequently Asked Questions

Is 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] covered by Medicare Part D?

Yes, 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] is covered by 27 Medicare Part D plans (0.5% of all Part D formularies).

What tier is 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] on Medicare Part D plans?

168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] averages Tier 3.5 across Part D plans, ranging from Tier 2 to Tier 4.

Does 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] require prior authorization?

25% of Part D formularies require prior authorization for 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar]. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar]?

In 2023, total Medicare Part D spending on 168 HR estradiol 0.000583 MG/HR Transdermal System [Menostar] was $611,837, covering 404 beneficiaries. The average spend per beneficiary was $1,514.45.

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare Editorial